Stock 4882 PERSEUS PROTEOMICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Perseus Proteomics Inc.

Equities

4882

JP3836800007

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-05-31 am EDT 		5-day change 1st Jan Change
325 JPY +5.18% Intraday chart for Perseus Proteomics Inc. -0.61% -47.41%
May. 10 Perseus Proteomics Inc. Announces on Delay in the End of Phase I Clinical Trial for Polycythemia Vera CI
Mar. 07 Perseus Proteomics Inc. announced that it has received ¥1.566 million in funding from Barclays Bank PLC (Tokyo Branch) CI

Business Summary

Perseus Proteomics Inc is a Japan-based company principally engaged in the research, development, manufacture and sale of pharmaceuticals. The Company is involved in the research and development of therapeutic drugs for cancer and other diseases and related businesses. The Company is involved in the research, development, licensing, and manufacturing method establishment for commercialization in the fields of drug discovery, antibody research support, as well as antibody and reagent sales. The products include PPMX-T001, a therapeutic agent that targets glypican 3 (GPC3) present on the surface of cancer cell membranes; PPMX-T002, a therapeutic agent that targets cadherin 3 (CDH3) present on the surface of cancer cells; PPMX-T003, a therapeutic agent that targets the transferrin receptor (TfR); PPMX-T004 therapeutic agent targeting cadherin 3 (CDH3) and others.

Number of employees: 24

Sales per Business

JPY in Million2022Weight2023Weight Delta
Pharmaceutical
100.0 %
72 100.0 % 94 100.0 % +30.96%

Sales per region

JPY in Million2022Weight2023Weight Delta
United States
54.2 %
37 51.2 % 51 54.2 % +38.57%
Japan
45.8 %
35 48.8 % 43 45.8 % +22.96%

Managers

Managers TitleAgeSince
Takuya Yokogawa PSD
 President 63 18-02-28
Tadashi Matsuura CTO
 Chief Tech/Sci/R&D Officer 65 05-04-30
Yasuo Ichinose ADM
 Chief Administrative Officer - -
Shinichi Suzukawa ADM
 Chief Administrative Officer 68 19-05-31

Members of the board

Members of the board TitleAgeSince
Takao Hamakubo BRD
 Director/Board Member - -
Nobuo Hanai BRD
 Director/Board Member 71 21-02-28
Shinichi Suzukawa ADM
 Chief Administrative Officer 68 19-05-31
Takuya Yokogawa PSD
 President 63 18-02-28
Kinichiro Kominami BRD
 Director/Board Member 57 18-05-31
Takashi Ono BRD
 Director/Board Member 54 21-05-31
Yasuo Ichinose ADM
 Chief Administrative Officer - -
Tadashi Matsuura CTO
 Chief Tech/Sci/R&D Officer 65 05-04-30
Nobuo Hanai BRD
 Director/Board Member - -
Tatsuya Nagakiyo BRD
 Director/Board Member 67 22-06-22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 13,053,800 11,731,243 ( 89.87 %) 50 ( 0.000383 %) 89.87 %

Shareholders

NameEquities%Valuation
Nippon Venture Capital Corp.
4.804 %
587,370 4.804 % 1 M ¥
FUJIFILM HOLDINGS CORPORATION
3.975 %
486,010 3.975 % 1 M ¥
DBJ Capital Co. Ltd.
2.817 %
344,400 2.817 % 750 671 ¥
Newton Biocapital Partners SRL
2.692 %
329,200 2.692 % 717 541 ¥
Mitsubishi UFJ Capital Co., Ltd.
2.330 %
284,910 2.330 % 621 004 ¥
Axil Capital Partners LLP
1.637 %
200,200 1.637 % 436 366 ¥
M3, INC.
0.7884 %
96,400 0.7884 % 210 118 ¥
SBI Investment Co., Ltd.
0.7238 %
88,500 0.7238 % 192 899 ¥
CMIC HLDG
0.4907 %
60,000 0.4907 % 130 779 ¥
Takuya Yokogawa
0.2454 %
30,000 0.2454 % 65 390 ¥

Company contact information

Perseus Proteomics, Inc.

4-7-6 Komaba Meguro-Ku

153-0041, Tokyo

+

http://www.ppmx.com
address Perseus Proteomics Inc.(4882)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
PERSEUS PROTEOMICS INC. Stock Perseus Proteomics Inc.
-47.41% 24.31M
CSL LIMITED Stock CSL Limited
-2.29% 89.38B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
-3.95% 37.92B
BIOGEN INC. Stock Biogen Inc.
-13.07% 32.04B
UCB Stock UCB
+63.05% 26.03B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-22.14% 14.14B
INCYTE CORPORATION Stock Incyte Corporation
-7.96% 12.88B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-9.33% 11.77B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-46.33% 10.85B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+5.77% 8.92B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 4882 Stock
  4. Company Perseus Proteomics Inc.